Quick Takeaways
- GekkoVet has partnered with Royal Canin to roll out its AI-driven clinical decision support platform in Mexico, marking their first national expansion in Latin America.
- The platform provides real-time diagnostics, treatment guidance, and drug information, helping veterinarians make faster, evidence-based decisions while improving workflow efficiency and patient outcomes.
- Building on earlier success in Asia, the collaboration blends nutrition expertise with AI technology, with plans to expand across Latin America following this initial rollout.
Why It Matters?
The partnership allows GekkoVet to scale rapidly in a new geography by leveraging Royal Canin’s established veterinary relationships, positioning its AI platform as an embedded part of day-to-day clinical practice.
For Royal Canin, integrating clinical decision support with its nutrition portfolio deepens its role in case management, potentially influencing diet recommendations and strengthening brand loyalty among clinics.
Successful deployment in Mexico can serve as a proof point for wider Latin American expansion, accelerating the adoption of AI-assisted workflows in a region where demand for modern, efficient veterinary care is rising.
Source: Businesswire
